261 related articles for article (PubMed ID: 30760325)
1. Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome.
Quinn RA; Adem S; Mills RH; Comstock W; DeRight Goldasich L; Humphrey G; Aksenov AA; Melnik AV; da Silva R; Ackermann G; Bandeira N; Gonzalez DJ; Conrad D; O'Donoghue AJ; Knight R; Dorrestein PC
Microbiome; 2019 Feb; 7(1):23. PubMed ID: 30760325
[TBL] [Abstract][Full Text] [Related]
2. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
3. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
4. Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.
Al-Momani H; Perry A; Stewart CJ; Jones R; Krishnan A; Robertson AG; Bourke S; Doe S; Cummings SP; Anderson A; Forrest T; Griffin SM; Brodlie M; Pearson J; Ward C
Sci Rep; 2016 Jun; 6():26985. PubMed ID: 27245316
[TBL] [Abstract][Full Text] [Related]
5. Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome.
Quinn RA; Phelan VV; Whiteson KL; Garg N; Bailey BA; Lim YW; Conrad DJ; Dorrestein PC; Rohwer FL
ISME J; 2016 Jun; 10(6):1483-98. PubMed ID: 26623545
[TBL] [Abstract][Full Text] [Related]
6. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
[TBL] [Abstract][Full Text] [Related]
7. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
[TBL] [Abstract][Full Text] [Related]
8. The metabolic footprint of the airway bacterial community in cystic fibrosis.
Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
[TBL] [Abstract][Full Text] [Related]
9. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
[TBL] [Abstract][Full Text] [Related]
10. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
[TBL] [Abstract][Full Text] [Related]
11. Lung and Gut Microbiota Changes Associated with
Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
[TBL] [Abstract][Full Text] [Related]
12. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
[TBL] [Abstract][Full Text] [Related]
15. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
16. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
[TBL] [Abstract][Full Text] [Related]
18. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
Spasenovski T; Carroll MP; Payne MS; Bruce KD
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
[TBL] [Abstract][Full Text] [Related]
20. Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.
Forde E; Humphreys H; Greene CM; Fitzgerald-Hughes D; Devocelle M
Antimicrob Agents Chemother; 2014; 58(2):978-85. PubMed ID: 24277028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
